布地奈德结构式
|
常用名 | 布地奈德 | 英文名 | Budesonide |
|---|---|---|---|---|
| CAS号 | 51333-22-3 | 分子量 | 430.534 | |
| 密度 | 1.3±0.1 g/cm3 | 沸点 | 599.7±50.0 °C at 760 mmHg | |
| 分子式 | C25H34O6 | 熔点 | 221-232ºC (dec.) | |
| MSDS | 中文版 美版 | 闪点 | 201.8±23.6 °C |
布地奈德用途【用途一】 治疗皮肤病、哮喘等。 |
| 中文名 | 左布地奈德 |
|---|---|
| 英文名 | budesonide |
| 中文别名 | 16alpha,17alpha-22R,S-丙基亚甲基二氧-孕甾-1,4-二烯-11beta,21-二羟基-3,20二酮 |
| 英文别名 | 更多 |
| 描述 | Budesonide是一种具有强效抗炎活性的糖皮质类固醇。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 沸点 | 599.7±50.0 °C at 760 mmHg |
| 熔点 | 221-232ºC (dec.) |
| 分子式 | C25H34O6 |
| 分子量 | 430.534 |
| 闪点 | 201.8±23.6 °C |
| 精确质量 | 430.235535 |
| PSA | 93.06000 |
| LogP | 3.14 |
| 外观性状 | 白色固体 |
| 蒸汽压 | 0.0±3.9 mmHg at 25°C |
| 折射率 | 1.592 |
| 储存条件 | 库房通风低温干燥 |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 危害码 (欧洲) | Xn:Harmful |
| 风险声明 (欧洲) | R40 |
| 安全声明 (欧洲) | S22-S36 |
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 3 |
| RTECS号 | TU3723000 |
| 海关编码 | 29372900 |
| 海关编码 | 29372900 |
|---|
|
Processing of pharmaceutical materials by electrospraying under reduced pressure.
Drug Dev. Ind. Pharm. 41(1) , 116-23, (2014) Electrospraying was used in drug particle production.The aim of the research was to evaluate the possibilities to produce drug particles with desired pharmaceutical properties by electrospraying. In p... |
|
|
In Vitro Assessment of Uptake and Lysosomal Sequestration of Respiratory Drugs in Alveolar Macrophage Cell Line NR8383.
Pharm. Res. 32 , 3937-51, (2015) To assess accumulation and lysosomal sequestration of 9 drugs used in respiratory indications (plus imipramine as positive control) in the alveolar macrophage (AM) cell line NR8383.For all drugs, upta... |
|
|
Bsm1 vitamin D receptor polymorphism and calcium homeostasis following bariatric surgery.
J. Invest. Surg. 28(1) , 8-17, (2015) To evaluate the association between the Bsm1 vitamin D receptor polymorphism and the calcium-vitamin D-parathormone axis following bariatric surgery.This cross-sectional study included 86 morbidly obe... |
| Budesonide |
| Respules |
| Spirocort |
| Bidien |
| 2H-Naphth[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, 4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-5-hydroxy-6b-(2-hydroxyacetyl)-4a,6a-dimethyl-8-propyl-, (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)- |
| Budesonide,(11β,16α)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione |
| S-1320 |
| 16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione |
| EINECS 257-139-7 |
| Budeson |
| Micronyl |
| Pulmicort |
| MFCD00083259 |
| ENTOCORT |
| Rhinocort |
| (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-6b-Glycoloyl-5-hydroxy-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one |
| 2H-naphth[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, 4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-, (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)- |
| PREFERID |